Follow
Cristian Lasagna-Reeves
Cristian Lasagna-Reeves
Indiana University School of Medicine
Verified email at iu.edu - Homepage
Title
Cited by
Cited by
Year
Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice
C Lasagna-Reeves, D Gonzalez-Romero, MA Barria, I Olmedo, A Clos, ...
Biochemical and biophysical research communications 393 (4), 649-655, 2010
7242010
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, AL Clos, ...
Molecular neurodegeneration 6, 1-14, 2011
6182011
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, J Sarmiento, ...
The FASEB Journal 26 (5), 1946, 2012
5552012
Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, ...
Scientific reports 2 (1), 700, 2012
5482012
Molecular mechanisms of amyloid oligomers toxicity
R Kayed, CA Lasagna-Reeves
Journal of Alzheimer's Disease 33 (s1), S67-S78, 2013
5412013
Preparation and characterization of neurotoxic tau oligomers
CA Lasagna-Reeves, DL Castillo-Carranza, MJ Guerrero-Muņoz, ...
Biochemistry 49 (47), 10039-10041, 2010
3732010
Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles
DL Castillo-Carranza, U Sengupta, MJ Guerrero-Muņoz, ...
Journal of Neuroscience 34 (12), 4260-4272, 2014
3022014
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
SM Bemiller, TJ McCray, K Allan, SV Formica, G Xu, G Wilson, ...
Molecular neurodegeneration 12, 1-12, 2017
2412017
Specific targeting of tau oligomers in htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds
DL Castillo-Carranza, JE Gerson, U Sengupta, MJ Guerrero-Muņoz, ...
Journal of Alzheimer's Disease 40 (s1), S97-S111, 2014
1882014
Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies
U Sengupta, MJ Guerrero-Muņoz, DL Castillo-Carranza, ...
Biological psychiatry 78 (10), 672-683, 2015
1792015
Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain
CA Lasagna-Reeves, CG Glabe, R Kayed
Journal of Biological Chemistry 286 (25), 22122, 2011
1712011
Reduction of Nuak1 decreases tau and reverses phenotypes in a tauopathy mouse model
CA Lasagna-Reeves, M de Haro, S Hao, J Park, MWC Rousseaux, ...
Neuron 92 (2), 407-418, 2016
1432016
TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
MWC Rousseaux, M de Haro, CA Lasagna-Reeves, A De Maio, J Park, ...
elife 5, e19809, 2016
1092016
Characterization of tau oligomeric seeds in progressive supranuclear palsy
JE Gerson, U Sengupta, CA Lasagna-Reeves, MJ Guerrero-Muņoz, ...
Acta neuropathologica communications 2, 1-9, 2014
1002014
Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity
CA Lasagna-Reeves, AL Clos, D Castillo-Carranza, U Sengupta, ...
Biochemical and biophysical research communications 430 (3), 963-968, 2013
982013
The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
CA Lasagna-Reeves, U Sengupta, D Castillo-Carranza, JE Gerson, ...
Acta neuropathologica communications 2, 1-13, 2014
822014
Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies
C A Lasagna-Reeves, D L Castillo-Carranza, G R Jackson, R Kayed
Current Alzheimer Research 8 (6), 659-665, 2011
812011
Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease
MJ Guerrero-Muņoz, DL Castillo-Carranza, S Krishnamurthy, ...
Neurobiology of disease 71, 14-23, 2014
682014
Inhaled insulin forms toxic pulmonary amyloid aggregates
CA Lasagna-Reeves, AL Clos, T Midoro-Hiriuti, RM Goldblum, ...
Endocrinology 151 (10), 4717, 2010
562010
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer’s disease
M Moutinho, SS Puntambekar, AP Tsai, I Coronel, PB Lin, BT Casali, ...
Science translational medicine 14 (637), eabl7634, 2022
482022
The system can't perform the operation now. Try again later.
Articles 1–20